A cross-sectional study found that while the Inflation Reduction Act capped out-of-pocket drug costs for Medicare Part D beneficiaries at $2,000 starting in 2025, many enrollees may still face higher ...

Medicare enrollees who buy the optional Part D drug benefit may see substantial premium price hikes — potentially up to $50 a month — when they shop for next year’s coverage.

A JAMA study published Aug. 18 found that plan design changes by Medicare Part D insurers, particularly for Medicare Advantage plans, following passage of the Inflation Reduction Act of 2022 could ...

Environmental Protection Agency Director Lee Zeldin told Miranda Devine, during an interview on her "Pod Force One" podcast, that $20 billion was laundered through a network of "pass-through" NGOs ...

The Environmental Protection Agency (EPA) has canceled more than $29 billion in federal grants, a move the agency’s administrator, Lee Zeldin, says is ...

Since 2023, the Inflation Reduction Act (IRA) has capped the cost of insulin for Medicare beneficiaries at $35 per month.

The Environmental Protection Agency (EPA) has canceled more than $29 billion in federal grants, said Administrator Lee Zeldin ...

A new study finds Medicare beneficiaries are facing higher deductibles and cost-sharing requirements following changes ...

Cheaper energy bills are a nonpartisan issue—no matter where you live. The second Trump administration is proving to be more ...

President Trump’s tax bill is about to end a number of tax credits for homeowners who install clean energy appliances. But some people are racing to beat the deadline.

Pursuing bipartisan climate action has two main advantages. One is that it decreases the risk of backsliding. Climate change is a long-term problem that requires long-term solutions, not IRA-style ...

It's time to regroup After spending months trying to predict what would happen to the Inflation Reduction Act under the Trump ...